Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Sonoma Pharmaceuticals Q2 EPS $(0.32) Misses $(0.31) Estimate, Sales $5.604M Beat $4.261M Estimate

Author: Benzinga Newsdesk | November 04, 2025 08:58am
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 45.76 percent increase over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $5.604 million which beat the analyst consensus estimate of $4.261 million by 31.52 percent. This is a 56.58 percent increase over sales of $3.579 million the same period last year.

Posted In: SNOA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist